SCHEMBL2193582

SCHEMBL2193582

COC(=O)c1ccc(COc2c(C)cc(C3(c4cc(C)c(OCc5ccc(C(=O)OC)cc5)c(C=O)c4)CCC(C(C)(C)C4CCC(c5cc(C)c(OCc6ccc(C(=O)OC)cc6)c(C=O)c5)(c5cc(C)c(OCc6ccc(C(=O)OC)cc6)c(C=O)c5)CC4)CC3)cc2C=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.39
LMNA P02545 5/20 0.39
MAPT P10636 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
SMN1; SMN2 Q16637 5/20 0.36
NPC1 O15118 4/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ERN1 O75460 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
HTT P42858 2/20 0.36
CYP3A4 P08684 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2194955 0.91 KDM4E (0.38) RAB9AALOX5APFEN1SMN1; SMN2NPC1
SCHEMBL2194092 0.82 ALDH1A1 (0.36) MAPTALDH1A1KDM4EHSD17B10KMT2A
SCHEMBL2190666 0.81 LMNA (0.36) RAB9ALMNAMAPTL3MBTL1ALOX5AP
SCHEMBL2192005 0.80 CD69 (0.36) LMNAALDH1A1TSHRHSD17B10KMT2A
SCHEMBL12419957 0.77 ALDH1A1 (0.41) MAPTL3MBTL1ALDH1A1TSHRKDM4E
SCHEMBL12419961 0.76 ALDH1A1 (0.37) HPGDALDH1A1TSHRKDM4EMAPK1
SCHEMBL12855089 0.74 ALDH1A1 (0.39) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL3451350 0.73 RAB9A (0.42) RAB9ALMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL12419995 0.73 ALDH1A1 (0.38) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL2192978 0.71 RXRA (0.34) RAB9AALOX5APFEN1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522868-B2 Tetrakis(ether-substituted formylphenyl) HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2016-12-20 US disclosed
US-20160016884-A1 NEW TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2016-01-21 US disclosed
US-20110172457-A1 TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED FROM THE SAME HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016884-A1 NEW TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) AHR, PAH, ALK RAB9A 4107/4885LMNA 3411/4885MAPT 3615/4885
US-20110172457-A1 TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED FROM THE SAME AHR, PAH, ARNT RAB9A 3939/4885LMNA 3268/4885MAPT 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.